Evolution of CTX-M-type β-lactamases in isolates of Escherichia coli infecting hospital and community patients
- 1 February 2005
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 25 (2), 157-162
- https://doi.org/10.1016/j.ijantimicag.2004.09.013
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Growing Group of Extended-Spectrum β-Lactamases: the CTX-M EnzymesAntimicrobial Agents and Chemotherapy, 2004
- Emergence of Two Klebsiella pneumoniae Isolates Harboring Plasmid-Mediated CTX-M-15 β-Lactamase in TaiwanAntimicrobial Agents and Chemotherapy, 2004
- Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Community and Private Health Care CentersAntimicrobial Agents and Chemotherapy, 2003
- Evaluation of Genotyping Large Numbers of Escherichia coli Isolates by Enterobacterial Repetitive Intergenic Consensus-PCRJournal of Clinical Microbiology, 2003
- Dissemination of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Pediatric Intensive Care UnitsJournal of Clinical Microbiology, 2003
- Effect of D240G substitution in a novel ESBL CTX-M-27Journal of Antimicrobial Chemotherapy, 2003
- Chromosome-Encoded Ambler Class A β-Lactamase of Kluyvera georgiana , a Probable Progenitor of a Subgroup of CTX-M Extended-Spectrum β-LactamasesAntimicrobial Agents and Chemotherapy, 2002
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Novel Cefotaximase (CTX-M-16) with Increased Catalytic Efficiency Due to Substitution Asp-240→GlyAntimicrobial Agents and Chemotherapy, 2001
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987